The hyperactivity disorder, usually referred to as ADHD, is an independent risk factor for several common and serious mental health issues, finds research published in the open access journal BMJ Mental Health.
It is associated with major depression, post traumatic stress disorder, the eating disorder anorexia nervosa, and suicide attempts, the findings show, prompting the researchers to recommend vigilance by health professionals in a bid to ward off these disorders later on.
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition in children and teens that extends into adulthood in up to around two thirds of cases. Worldwide, its prevalence is estimated to be around 5% in children/teens and 2.5% in adults.
Previous research has shown that consumption of plant-based foods is associated with healthy aging [2,3]. It can also help to decrease the risk of mortality [4], prevent the development of chronic diseases [5,6], and improve neurological health, such as by lowering the risk of dementia [7] and cognitive impairment [8].
This new study aimed to determine the influence of a plant-based diet on the aging trajectory of the middle-aged Asian population. Researchers recruited over 10,000 people 50 years and older in Taiwan. Participants provided health data four times during the eight years after enrollment, underwent physical examinations, and filled out relevant questionnaires.
Other questions to the experts in this canvassing invited their views on the hopeful things that will occur in the next decade and for examples of specific applications that might emerge. What will human-technology co-evolution look like by 2030? Participants in this canvassing expect the rate of change to fall in a range anywhere from incremental to extremely impactful. Generally, they expect AI to continue to be targeted toward efficiencies in workplaces and other activities, and they say it is likely to be embedded in most human endeavors.
The greatest share of participants in this canvassing said automated systems driven by artificial intelligence are already improving many dimensions of their work, play and home lives and they expect this to continue over the next decade. While they worry over the accompanying negatives of human-AI advances, they hope for broad changes for the better as networked, intelligent systems are revolutionizing everything, from the most pressing professional work to hundreds of the little “everyday” aspects of existence.
One respondent’s answer covered many of the improvements experts expect as machines sit alongside humans as their assistants and enhancers. An associate professor at a major university in Israel wrote, “In the coming 12 years AI will enable all sorts of professions to do their work more efficiently, especially those involving ‘saving life’: individualized medicine, policing, even warfare (where attacks will focus on disabling infrastructure and less in killing enemy combatants and civilians). In other professions, AI will enable greater individualization, e.g., education based on the needs and intellectual abilities of each pupil/student. Of course, there will be some downsides: greater unemployment in certain ‘rote’ jobs (e.g., transportation drivers, food service, robots and automation, etc.).”
A molecular assembler, as defined by K. Eric Drexler, is a “proposed device able to guide chemical reactions by positioning reactive molecules with atomic precision”. A molecular assembler is a kind of molecular machine. Some biological molecules such as ribosomes fit this definition. This is because they receive instructions from messenger RNA and then assemble specific sequences of amino acids to construct protein molecules. However, the term “molecular assembler” usually refers to theoretical human-made devices.
Beginning in 2007, the British Engineering and Physical Sciences Research Council has funded development of ribosome-like molecular assemblers. Clearly, molecular assemblers are possible in this limited sense. A technology roadmap project, led by the Battelle Memorial Institute and hosted by several U.S. National Laboratories has explored a range of atomically precise fabrication technologies, including both early-generation and longer-term prospects for programmable molecular assembly; the report was released in December, 2007. In 2008 the Engineering and Physical Sciences Research Council provided funding of 1.5 million pounds over six years for research working towards mechanized mechanosynthesis, in partnership with the Institute for Molecular Manufacturing, amongst others. Likewise, the term “molecular assembler” has been used in science fiction and popular culture to refer to a wide range of fantastic atom-manipulating nanomachines, many of which may be physically impossible in reality. Much of the controversy regarding “molecular assemblers” results from the confusion in the use of the name for both technical concepts and popular fantasies. In 1992, Drexler introduced the related but better-understood term “molecular manufacturing”, which he defined as the programmed “chemical synthesis of complex structures by mechanically positioning reactive molecules, not by manipulating individual atoms”.This article mostly discusses “molecular assemblers” in the popular sense. These include hypothetical machines that manipulate individual atoms and machines with organism-like self-replicating abilities, mobility, ability to consume food, and so forth. These are quite different from devices that merely (as defined above) “guide chemical reactions by positioning reactive molecules with atomic precision”. Because synthetic molecular assemblers have never been constructed and because of the confusion regarding the meaning of the term, there has been much controversy as to whether “molecular assemblers” are possible or simply science fiction. Confusion and controversy also stem from their classification as nanotechnology, which is an active area of laboratory research which has already been applied to the production of real products; however, there had been, until recently, no research efforts into the actual construction of “molecular assemblers”. Nonetheless, a 2013 paper by David Leigh’s group, published in the journal Science, details a new method of synthesizing a peptide in a sequence-specific manner by using an artificial molecular machine that is guided by a molecular strand. This functions in the same way as a ribosome building proteins by assembling amino acids according to a messenger RNA blueprint. The structure of the machine is based on a rotaxane, which is a molecular ring sliding along a molecular axle. The ring carries a thiolate group which removes amino acids in sequence from the axle, transferring them to a peptide assembly site. In 2018, the same group published a more advanced version of this concept in which the molecular ring shuttles along a polymeric track to assemble an oligopeptide that can fold into a α-helix that can perform the enantioselective epoxidation of a chalcone derivative (in a way reminiscent to the ribosome assembling an enzyme). In another paper published in Science in March 2015, chemists at the University of Illinois report a platform that automates the synthesis of 14 classes of small molecules, with thousands of compatible building blocks. In 2017 David Leigh’s group reported a molecular robot that could be programmed to construct any one of four different stereoisomers of a molecular product by using a nanomechanical robotic arm to move a molecular substrate between different reactive sites of an artificial molecular machine. An accompanying News and Views article, titled ‘A molecular assembler’, outlined the operation of the molecular robot as effectively a prototypical molecular assembler.
Scientists from the Babraham Institute suggest an alternative connection between diet and aging, based on studies in yeast. Dr. Jon Houseley and his team have published their experiments, demonstrating that healthy aging is achievable through dietary change without restriction by potentially optimizing diet and that ill health is not an inevitable part of the aging process.
Scientists have long known that caloric restriction – intentionally consuming far fewer calories than normal without becoming malnourished – improves health in later life and may even extend life. However, studies in mice show that caloric restriction really needs to be maintained throughout life to achieve this impact, and the health benefits disappear when a normal diet is resumed. Dr. Houseley’s new research conducted in yeast suggests an alternative to calorie restriction can lead to improved health throughout the lifecycle.
Dr. Kimathi is a medical oncologist in a community setting where she sees patients with a variety of cancer diagnoses. Recently, she had several patients with toxicities to different treatments, including tamoxifen, cisplatin, and methotrexate. Concerned, she wondered if there was a common factor these patients shared to have experienced these toxicities. On review, she found that these patients had different cancer diagnoses and did not share any known comorbidities or risk factors.
Why do some cancer patients experience toxicities from certain treatments and others don’t? Drug metabolism is highly variable among patients, and even within the same patient, depending on age and disease state. Both the toxicity and efficacy of cancer chemotherapy can be affected by many different factors, including other medications, foods, dietary supplements, environmental conditions, and genetic variants in drug-metabolizing genes and drug transporters.
A major _New York Times_ investigation reveals how the United States’ aquifers are becoming severely depleted due to overuse in part from huge industrial farms and sprawling cities. The _Times_ reports that Kansas corn yields are plummeting due to a lack of water, there is not enough water to support the construction of new homes in parts of Phoenix, Arizona, and rivers across the country are drying up as aquifers are being drained far faster than they are refilling. “It can take millions of years to fill an aquifer, but they can be depleted in 50 years,” says Warigia Bowman, director of sustainable energy and natural resources law at the University of Tulsa College of Law. “All coastal regions in the United States are really being threatened by groundwater and aquifer problems.”
Interfacing modern electronics-based technology with biology is notoriously difficult. One major stumbling block is that the way they are powered is very different. While most of our gadgets run on electrons, nature relies on the energy released when the chemical bonds of ATP are broken. Finding ways to convert between these two very different currencies of energy could be useful for a host of biotechnologies.
Genetically engineered microbes are already being used to produce various high-value chemicals and therapeutically useful proteins, and there are hopes they could soon help generate greener jet fuel, break down plastic waste, and even grow new foods in giant bioreactors. But at the minute, these processes are powered through an inefficient process of growing biomass, converting it to sugar, and feeding it to the microbes.
Now, researchers at the Max Planck Institute for Terrestrial Microbiology in Germany have devised a much more direct way to power biological processes. They have created an artificial metabolic pathway that can directly convert electricity into ATP using a cocktail of enzymes. And crucially, the process works in vitro and doesn’t rely on the native machinery of cells.
High-speed drone racing has just had a shocking “Deep Blue” moment, as an autonomous AI designed by University of Zurich researchers repeatedly forced three world champion-level pilots to eat its dust, showing uncanny precision in dynamic flight.
If you’ve ever watched a high-level drone race from the FPV perspective, you’ll know how much skill, speed, precision and dynamic control it takes. Like watching Formula One from the driver’s perspective, or on-board footage from the Isle of Man TT, it’s hard to imagine how a human brain can make calculations that quickly and respond to changing situations in real time. It’s incredibly impressive.
What happens when humans begin combining biology with technology, harnessing the power to recode life itself.
What does the future of biotechnology look like? How will humans program biology to create organ farm technology and bio-robots. And what happens when companies begin investing in advanced bio-printing, artificial wombs, and cybernetic prosthetic limbs.
